NMC Health (LON:NMC) had its price target increased by Jefferies Group from GBX 3,085 ($41.85) to GBX 3,291 ($44.64) in a research report released on Monday morning. They currently have a hold rating on the stock.

Other equities analysts have also issued research reports about the stock. Berenberg Bank lifted their target price on shares of NMC Health from GBX 4,000 ($54.26) to GBX 4,600 ($62.40) and gave the company a buy rating in a report on Friday, March 23rd. JPMorgan Chase lowered shares of NMC Health to a neutral rating and lifted their target price for the company from GBX 2,730 ($37.03) to GBX 3,270 ($44.36) in a report on Wednesday, January 24th. Finally, Barclays started coverage on shares of NMC Health in a report on Monday, April 23rd. They set an overweight rating and a GBX 4,250 ($57.65) target price on the stock.

Shares of NMC Health opened at GBX 3,618 ($49.08) on Monday, according to Marketbeat. NMC Health has a 52-week low of GBX 1,726 ($23.41) and a 52-week high of GBX 3,558 ($48.26).

The firm also recently announced a dividend, which will be paid on Tuesday, July 10th. Investors of record on Thursday, June 14th will be issued a dividend of GBX 13 ($0.18) per share. This is a positive change from NMC Health’s previous dividend of $10.60. The ex-dividend date is Thursday, June 14th. This represents a dividend yield of 0.38%.

About NMC Health

NMC Health Plc provides healthcare services in the United Arab Emirates and internationally. It operates through two businesses, NMC Healthcare and NMC Trading. The company owns and manages approximately 135 healthcare facilities that include hospitals, medical centers, long term care facilities, day surgery centers, fertility centers, and home health services providers.

Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.